Guizhou Xinbang Pharmaceutical Co., Ltd.
SHZ: 002390.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Lingzhong Kong
- Employees
- 5,059
- Headquarters
- Guiyang, China
- IPO year
- 2010
- Market cap
- CN¥6.5B
- Website
- https://www.xinbang.com
Loading 002390…
Loading profile data…Frequently asked questions about 002390
What does Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) do?
Guizhou Xinbang Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of Chinese herbal medicines and biological drugs in China and internationally. It offers cardiovascular and cerebrovascular, digestive system, endocrine, tumor and immune regulation, blood system, rheumatism and rheumatoid, urinary system, antipy...
Where does 002390.SZ trade?
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002390.SZ in?
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Guizhou Xinbang Pharmaceutical Co., Ltd.?
Lingzhong Kong is the chief executive officer of Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ).
Where is Guizhou Xinbang Pharmaceutical Co., Ltd. headquartered?
Guizhou Xinbang Pharmaceutical Co., Ltd. is headquartered in China.
Does 002390.SZ pay a dividend?
Yes — Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) paid a trailing twelve-month dividend of CNY 0.06 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002390.SZ go public?
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) completed its initial public offering in 2010.